Privia Health
PRVA
218 hedge funds and large institutions have $2.55B invested in Privia Health in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 90 increasing their positions, 71 reducing their positions, and 42 closing their positions.
432% more call options, than puts
Call options by funds: $5.48M | Put options by funds: $1.03M
27% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 71
0.19% more ownership
Funds ownership: 94.43% → 94.62% (+0.19%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 234 → 218 (-16)
10% less capital invested
Capital invested by funds: $2.85B → $2.55B (-$298M)
33% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$63.3M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$15.5M |
| 3 |
State Street
Boston,
Massachusetts
|
+$12.4M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$11.8M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$7.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$21.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$14.9M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$13.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.6M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$10.2M |
PRVA Hedge Fund Activity: Q3 2023 in Review
218 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q3 2023, worth a combined $2.55B — down 10% from $2.85B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of PRVA and 28 opened new positions — a net loss of 14 holders — while 71 trimmed existing stakes and 90 added.
The largest buyer was BlackRock, adding an estimated $63.3M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $21.2M sold.
- 218 institutional investors held Privia Health (PRVA) as of Q3 2023, down from 234 in Q2 2023.
- Funds reported $2.55B of Privia Health stock for Q3 2023, down 10% quarter-over-quarter.
- 28 funds opened new Privia Health positions in Q3 2023 and 42 closed out, a net change of -14 holders.
- The largest Privia Health buyer in Q3 2023 was BlackRock, an estimated $63.3M added.
- The largest Privia Health seller in Q3 2023 was Alyeska Investment Group, an estimated $21.2M sold.
Based on aggregated 13F filings for Q3 2023.